A two‑year community lifestyle programme produced modest improvements in waist circumference, blood glucose and blood lipids among adults at elevated risk for type 2 diabetes — even though participants did not lose weight, according to research published Oct. 23 in Nutrition Journal.
What the study did
The Feel4Diabetes trial followed adults identified as at risk for type 2 diabetes by the Finnish Diabetes Risk Score across six European countries. Participants were offered a community intervention comprising group counselling in the first year and ongoing text‑message support in the second year. Outcomes were compared with a usual‑care control group. Diet quality was assessed via food questionnaires and activity measured by daily step counts.
Measured changes at two years
Body mass index (BMI) did not differ between the intervention and control groups at the end of the study, but several metabolic markers shifted in a favourable direction for the intervention group. The differences were modest in magnitude and measured in single digits.
| Measure (2‑year change) | Intervention | Control |
|---|---|---|
| Waist circumference | -1.1 cm | +1.1 cm |
| Fasting blood glucose | +1.1 mg/dL | +2.6 mg/dL |
| Total cholesterol | -6.7 mg/dL | -1.0 mg/dL |
| LDL cholesterol | -4.8 mg/dL | +0.4 mg/dL |
| Diastolic blood pressure | -0.8 mmHg | +0.7 mmHg |
What drove the improvements
The study authors linked the reduction in waist circumference to gains in both diet quality and physical activity. However, improvements in lipid measures — particularly total and LDL cholesterol — were associated primarily with diet changes rather than step‑count increases. That suggests dietary shifts may be more influential than modest increases in walking alone when it comes to improving lipid profiles.
- Community delivery: group sessions followed by text support made the programme accessible outside a tightly controlled trial setting.
- Diet measures: improved quality of food choices correlated with better cholesterol outcomes.
- Activity measures: step counts were linked to waist outcomes but not to lipid changes in isolation.
Important caveats: this was a community‑based comparison with usual care rather than a strictly controlled randomised trial, meaning other unmeasured differences between groups cannot be entirely excluded. The observed changes were small and it remains unknown whether they will translate into lower rates of diabetes or cardiovascular disease over the long term.
Practical takeaways for readers
For people worrying that an unchanged number on the scale means progress has failed, these results offer a different perspective. Waist circumference and metabolic markers can move in healthier directions even when BMI remains steady. If diabetes risk is a concern, the trial reinforces a pragmatic emphasis on improving overall diet quality — more fibre and vegetables and healthier fats — alongside increasing routine activity.
That approach is actionable: focus on small, sustainable food changes and consistent movement rather than short‑term weight loss. Community‑level programmes combining education and ongoing prompts — such as group counselling followed by text reminders — can support those gradual shifts.
While the gains reported are modest and not a substitute for clinical care, they suggest measurable benefits from realistic, population‑level lifestyle support. Further research will be needed to determine whether such changes reduce disease events over time.
